Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative IV Lidocaine in Robotic Urologic Surgery
NCT03824808Phase 4Terminated
- Sponsor
- University of Missouri
- Start
- Feb 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in prostate cancer (PCa) and kidney cancer comparing Lidocaine Group with Placebo Group (2 arms). Primary endpoint: Difference in Post-operative Pain Scores Measured by Visual Analog Scale at 21 days. Started Feb 2019; status: terminated.
02
Drugs
lidocaine
03
Conditions
prostate cancer (PCa)kidney cancer
Beyond the preview
Go deeper on NCT03824808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03824808.